Multiple genetic alterations in human carcinogenesis.
Cancer development in man appeared to be a multistage process as suggested by epidemiological studies on commonly occurring gastric, colon, and breast cancers and also on human retrovirus-related leukemia, and by the finding by physicians and surgeons of precancerous lesions for many types of neoplasias. In the last 10 years it has become evident that human cancers have multiple genetic alterations caused by point mutations, recombinations, amplifications, and/or deletions. The genes affected include both oncogenes and tumor-suppressor genes and genes that accelerate cell proliferation and metastasis. Cancers with more malignant properties and poorer prognosis are generally associated with larger numbers of genetic alterations. These multiple genetic alterations are considered to be a direct reflection of the multiple steps involved in carcinogenesis. The multiple genetic alterations are caused by multiple environmental carcinogenic substances or factors, each of which usually exists only at minute concentrations and does not exert any major impact alone except under particular occupational, iatrogenic, and locally geographic conditions. The fact that carcinogenesis is a multistep process involving multiple genetic alterations clearly needs to be taken into consideration in assessing the risks of environmental carcinogenic substances or factors. The increasing incidence of multiple primary cancers is also most easily understood from the viewpoint of multiple steps in carcinogenesis. Possible multiple approaches to cancer prevention should therefore be considered in relation to multistep carcinogenesis and multiple carcinogenic factors.
Sugimura
T
T
National Cancer Center Research Institute, Tokyo, Japan.
Terada
M
M
Yokota
J
J
Hirohashi
S
S
Wakabayashi
K
K
D000818:Animals; D002274:Carcinogens, Environmental / Q000009:adverse effects; D003043:Cocarcinogenesis; D016147:Genes, Tumor Suppressor / Q000235:genetics; D006801:Humans; D051379:Mice; D016296:Mutagenesis / Q000235:genetics*; D009369:Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000628:therapy; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology; D011519:Proto-Oncogenes / Q000235:genetics*; D051381:Rats; D012306:Risk
D002274:Carcinogens, Environmental